We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$20.6B
AUM Growth
+$404M
Cap. Flow
-$918M
Cap. Flow %
-4.46%
Top 10 Hldgs %
45.88%
Holding
486
New
43
Increased
157
Reduced
204
Closed
61

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$271M
2
CEG icon
Constellation Energy
CEG
+$108M
3
HUBS icon
HubSpot
HUBS
+$83.9M
4
AAPL icon
Apple
AAPL
+$83.5M
5
EQIX icon
Equinix
EQIX
+$56.3M

Sector Composition

Rank Sector Weight
1 Technology 41.24%
2 Healthcare 15.44%
3 Communication Services 13.11%
4 Consumer Discretionary 10.67%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANRO icon
351
Alto Neuroscience
ANRO
$1.07B
$1.24M 0.01%
116,254
-1,762
-1% -$22.9K
FLEX icon
352
Flex
FLEX
$41.5B
$1.18M 0.01%
39,888
-2,674
-6% -$80.1K
ITCI
353
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.13M 0.01%
16,564
+4,030
+32% +$280K
ORIC icon
354
Oric Pharmaceuticals
ORIC
$1.23B
$1.1M 0.01%
155,912
-64,031
-29% -$573K
ONTO icon
355
Onto Innovation
ONTO
$12B
$1.1M 0.01%
+5,003
New +$1.03M
CDXS icon
356
Codexis
CDXS
$161M
$1.08M 0.01%
349,490
-158,605
-31% -$509K
DLR icon
357
Digital Realty Trust
DLR
$71.5B
$1.07M 0.01%
7,035
+3,273
+87% +$470K
ACN icon
358
Accenture
ACN
$101B
$1.04M 0.01%
3,413
+94
+3% +$28.8K
FBRX icon
359
Forte Biosciences
FBRX
$1.57B
$988K ﹤0.01%
73,559
ENSG icon
360
The Ensign Group
ENSG
$10.7B
$908K ﹤0.01%
+7,342
New +$875K
RVMD icon
361
Revolution Medicines
RVMD
$39.1B
$845K ﹤0.01%
+21,764
New +$813K
PDD icon
362
Pinduoduo
PDD
$122B
$804K ﹤0.01%
6,047
+1,630
+37% +$221K
NRIX icon
363
Nurix Therapeutics
NRIX
$2.51B
$794K ﹤0.01%
+38,066
New +$593K
FSLR icon
364
First Solar
FSLR
$21.8B
$787K ﹤0.01%
3,491
+635
+22% +$138K
ZTS icon
365
Zoetis
ZTS
$32.5B
$689K ﹤0.01%
3,973
-511
-11% -$85K
ADSK icon
366
Autodesk
ADSK
$50.1B
$646K ﹤0.01%
2,612
-572
-18% -$128K
PTC icon
367
PTC
PTC
$14.7B
$639K ﹤0.01%
3,516
+266
+8% +$47.6K
RNAM
368
DELISTED
Avidity Biosciences
RNAM
$638K ﹤0.01%
+15,625
New +$448K
DNLI icon
369
Denali Therapeutics
DNLI
$3.82B
$627K ﹤0.01%
+27,014
New +$519K
XYL icon
370
Xylem
XYL
$29.2B
$600K ﹤0.01%
4,421
A icon
371
Agilent Technologies
A
$39.7B
$599K ﹤0.01%
4,624
SAIA icon
372
Saia
SAIA
$10.9B
$551K ﹤0.01%
1,162
-342
-23% -$159K
QTRX icon
373
Quanterix
QTRX
$164M
$535K ﹤0.01%
40,495
-603
-1% -$10.1K
DE icon
374
Deere & Co
DE
$173B
$509K ﹤0.01%
1,362
ROP icon
375
Roper Technologies
ROP
$38.7B
$504K ﹤0.01%
894

Similar funds

Fred Alger Management's Q2 2024 Portfolio in Review

As of Q2 2024, Fred Alger Management held 486 positions worth $20.6B, up 2% from $20.2B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Fred Alger Management withdrew a net $918M in Q2 2024, closing 61 positions and reducing 204 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $67.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Fred Alger Management opened a new position in Applovin worth $291M.

  • Fred Alger Management's largest Q2 2024 buy was Applovin: 3,492,613 shares worth $291M.
  • Fred Alger Management added most to Constellation Energy in Q2 2024, an estimated $108M increase.
  • Fred Alger Management's biggest Q2 2024 reduction was Natera, cutting an estimated $130M.
  • Fred Alger Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $67.4M.
  • Fred Alger Management's ten largest holdings make up 46% of its $20.6B portfolio in Q2 2024.
  • Fred Alger Management opened 43 new positions and closed 61 in Q2 2024.
  • Fred Alger Management's portfolio value rose 2% quarter-over-quarter to $20.6B.

Based on Fred Alger Management's 13F filing for Q2 2024, filed 14 Aug 2024.